Walleye Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Sell
93,100
-172,100
-65% -$3M 0.01% 1446
2025
Q4
$3.13M Buy
265,200
+31,300
+13% +$402K 0.01% 1504
2025
Q3
$3.7M Buy
233,900
+74,400
+47% +$1.08M 0.01% 1120
2025
Q2
$1.83M Buy
159,500
+43,900
+38% +$495K 0.01% 1588
2025
Q1
$1.56M Buy
115,600
+77,900
+207% +$1.29M 0.01% 1627
2024
Q4
$637K Sell
37,700
-33,000
-47% -$642K ﹤0.01% 2785
2024
Q3
$1.44M Buy
70,700
+25,500
+56% +$521K ﹤0.01% 2274
2024
Q2
$1.02M Buy
45,200
+35,400
+361% +$927K ﹤0.01% 2829
2024
Q1
$257K Sell
9,800
-1,700
-15% -$48.4K ﹤0.01% 3786
2023
Q4
$363K Sell
11,500
-13,900
-55% -$377K ﹤0.01% 3211
2023
Q3
$712K Sell
25,400
-200
-0.8% -$6.87K ﹤0.01% 2529
2023
Q2
$944K Sell
25,600
-2,400
-9% -$73.3K ﹤0.01% 1896
2023
Q1
$838K Buy
+28,000
New +$922K 0.01% 1298
2022
Q4
Sell
-1,000
Closed -$25K 3211
2022
Q3
$25K Buy
+1,000
New +$33K ﹤0.01% 2692
2020
Q1
Sell
-23,100
Closed -$418K 1009
2019
Q4
$418K Sell
23,100
-70,500
-75% -$1.17M 0.03% 768
2019
Q3
$1.4M Buy
93,600
+91,400
+4,155% +$1.49M 0.08% 327
2019
Q2
$53K Sell
2,200
-3,000
-58% -$88.4K 0.01% 1370
2019
Q1
$193K Buy
+5,200
New +$189K 0.03% 796

Other funds holding CC

Walleye Capital's CC Position: Q1 2026 in Review

Walleye Capital increased its Chemours (CC) stake by 52% in Q1 2026, buying an estimated $887K and bringing the position to 148,005 shares worth $3.26M. The position accounts for 0.01% of the portfolio, ranked #1077.

Walleye Capital first reported a position in CC in Q1 2019 and has held it in 12 quarters since. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Walleye Capital held 148,005 shares of Chemours worth $3.26M as of Q1 2026.
  • Walleye Capital bought 50,946 Chemours shares in Q1 2026, an estimated $887K.
  • Chemours made up 0.01% of Walleye Capital's portfolio in Q1 2026, its #1077 holding.
  • Walleye Capital first reported a position in Chemours in Q1 2019 and has held it in 12 quarters since.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.